European Journal of Clinical Pharmacology · 1996 · 321 citations · 32 references
MedicinePharmacokineticsPharmacologyDrug InteractionsPharmacodynamicsPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyCytochrome P450 EnzymesCytochrome P450 InteractionsCytochrome P450-mediated MetabolismCyp1a2 Drug MetabolismCyp2d6 Drug MetabolismCytochrome P450 Enzyme Inhibition
32
Marguerite A. Butler, M. Iwasaki, F. Peter Guengerich et al. · Proceedings of the National Academy of Sciences · 1989 · 638 citations · Full text
Medicine, Pharmacology, Toxicology +17
Fluvoxamine is a potent inhibitor of cytochrome P4501A2
Kim Brøsen, Erik Skjelbo, Birgitte Buur Rasmussen et al. · Biochemical Pharmacology · 1993 · 372 citations
Evidence That CYP2C19 is the Major (S)-Mephenytoin 4'-Hydroxylase in Humans
Jorge Goldstein, M B Faletto, M Romkes-Sparks et al. · Biochemistry · 1994 · 363 citations
Medicine, Biochemistry, Pharmacology +10